(Q37748657)

22 August 2017

1 reference

title

Revisiting the role of IL-2 in autoimmunity (English)

1 reference

22 August 2017

2

Abul K Abbas

1 reference

22 August 2017

Hans Dooms

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

European Journal of Immunology

22 August 2017

published in

1 reference

22 August 2017

volume

40

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

1538-1540

1 reference

Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

IL-2 induces a competitive survival advantage in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

Interleukin-2: inception, impact, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Interleukin-2 therapy in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

A function for interleukin 2 in Foxp3-expressing regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

The initial phase of an immune response functions to activate regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Interleukin 2 plays a central role in Th2 differentiation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7R alpha-expressing cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040617

7 January 2021

Identifiers

DOI

10.1002/EJI.201040617

1 reference

22 August 2017

1 reference